Moderna’s non-vaccine mRNA therapeutic set to generate $278 million in 2028 if approved, estimates GlobalData

According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year

Thermo Fisher Scientific launches real-time PCR kits for detection of infectious diseases in India

The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care

Windlas Biotech appoints Komal Gupta as CEO

The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO

Pharma companies developing vaccines with efficacy against Omicron variants will gain competitive advantage in China, says GlobalData

The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.

CrisprBits develops CRISPR-based SARS-CoV2 test OmiCrisp

OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program

Genome sequencing solutions will help to bring precision in lung cancer therapy, says GlobalData

APAC region contributed around 50% of the in-vitro diagnostics market in 2022

Moderna to acquire Oriciro Genomics

OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines

Blacksmith announces merger with Forge Therapeutics

To create leading company developing medicines targeting metalloenzymes

CDSCO playing a significant role in providing right medicine at the right time: Dr. Mandaviya

PM dedicates AIIMS Nagpur to the nation

The hospital is being developed at a cost of more than Rs. 1,575 crore